Related Experiment Video
Updated: Jan 30, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling
Sakshi Gera1, Sandeep Kumar S2, Shalini N Swamy2
1Department of Molecular Reproduction Development and Genetics, Indian Institute of Science, Bengaluru, India.
Abstract:
The association between the upregulated Notch and FSH signaling and ovarian cancer is well documented. However, their signaling has been investigated independently and only in the primary tumor tissues. The aim of this study was to investigate the interactive effects of FSH and Notch signaling on ovarian cancer proliferation, formation, and maintenance of disseminated ovarian cancer cells. The roles of Notch and FSH in ovarian cancer pathogenesis were investigated with ovarian cancer cell lines and specific antibodies against Notch and FSH receptor (FSHR). FSH upregulated Notch signaling and proliferation in ovarian cancer cells. High levels of FSH were detected in the ascites of patients with serous ovarian adenocarcinoma. Spheroids from the patients' ascites, as well as the spheroids from ovarian cancer cell lines under low attachment culture conditions, expressed FSHβ subunit mRNA and secreted the hormone into the medium. In contrast, primary ovarian tumor tissues and cell line monolayers expressed very low levels of FSHβ. Ovarian cancer cell spheroids also exhibited higher expression of FSH receptor and Notch downstream genes than their monolayer counterparts. A combination of FSHR and Notch antagonistic antibodies significantly inhibited spheroid formation and cell proliferation in vitro. This study demonstrates that spheroids in ascites express and secrete FSH, which regulates cancer cell proliferation and spheroidogenesis through Notch signaling, suggesting that FSH is an autocrine regulator of cancer metastasis. Furthermore, Notch and FSHR are potential immunotherapeutic targets for ovarian cancer treatment.
Insights
Follicle-stimulating hormone (FSH) and Notch signaling interact to drive ovarian cancer progression and metastasis. Targeting FSH and Notch pathways offers a promising strategy for ovarian cancer immunotherapy.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Notch and FSH signaling are linked to ovarian cancer but studied independently.
- Previous research focused on primary tumor tissues, overlooking disseminated cells.
Purpose of the Study:
- Investigate the interactive effects of FSH and Notch signaling on ovarian cancer proliferation.
- Examine the role of these pathways in the formation and maintenance of disseminated ovarian cancer cells.
Main Methods:
- Utilized ovarian cancer cell lines and specific antibodies against Notch and FSH receptor (FSHR).
- Analyzed FSH levels in patient ascites and gene expression in spheroids versus monolayers.
- Assessed the impact of combined FSHR and Notch antagonistic antibodies on spheroid formation and proliferation.
Main Results:
- FSH upregulated Notch signaling and proliferation in ovarian cancer cells.
- Ovarian cancer spheroids in ascites expressed and secreted FSH, unlike primary tumors.
- Combined FSHR and Notch inhibition significantly reduced spheroid formation and proliferation in vitro.
Conclusions:
- FSH acts as an autocrine regulator of ovarian cancer metastasis via Notch signaling in spheroids.
- Notch and FSHR are potential targets for ovarian cancer immunotherapy.
Related Concept Videos
Hormonal Regulation
Hormonal Regulation
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Types of Hormones
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...

